INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes

Breast Cancer Research and Treatment

Volumn 37, Issue 1, 1996, Pages 65-76

  Pauley, R J ^a   Gimotty, P A ^a   Paine, T J ^a   Dawson, P J ^a   Wolman, S R ^a  

^a KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Amplification; Breast cancer; ERBB2; Expression; INT2

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVAL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; SOUTHERN BLOTTING; TUMOR RECURRENCE; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTORS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS; SURVIVAL RATE; SURVIVORS;

EID: 0030033369     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806633     Document Type: Article

References (0)